AUA2023: How to use PSMA-PET/CT in the Management of Relapsing Prostate Cancer Patients

AUA2023: How to use PSMA-PET/CT in the Management of Relapsing Prostate Cancer Patients following Local Therapy with Curative Intent

CME Expiration Date: May, 2024

ACKNOWLEDGEMENTS
Independent educational grant support provided by:
Astellas
AstraZeneca
Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC
Lantheus Medical Imaging
Merck & Co., Inc.
Pfizer, Inc.